2025 Course Highlights

ADDICTION MEDICINE

  • Management of complicated alcohol withdrawal
  • New protocols for use of phenobarbital in alcohol withdrawal
  • Microdosing protocols for buprenorphine induction
  • Oral vs IM naltrexone of alcohol use disorder
  • Harm reduction: reducing the risk of opiate overdose at discharge   
  • Best practice for treating pain in patients with substance use disorders
  • Does addiction treatment during hospitalization prevent readmission?

 

ALLERGY/IMMUNOLOGY

  • How to resolve low-risk penicillin allergy labels in the hospital
  • Is skin testing necessary before an oral penicillin challenge?
  • Updates in anaphylaxis management
  • Things we do for no reason: steroids for anaphylaxis?
  • Look out for “Neffy!”
  • Class action: sorting out the overlap between penicillin and cephalosporin allergy
  • What to do when there is no allergist
  • Management of IV contrast allergy

 

BEST PRACTICES

  • Inpatient pain management: state of the art
  • Management of patient-directed discharges
  • Discharge before noon: burden or boon?
  • Are cannabinoids the next frontier in chronic pain management?
  • Social determinants of health and the hospitalist
  • “As-needed” blood pressure medication: end of an error
  • Hospital-acquired infections are not equal across communities
  • Barriers and facilitators to caring for socially disadvantaged patients

 

CARDIOVASCULAR

  • New heart failure guidelines: should we stagger initiating quadruple GDMT?
  • Is less more in the long run? DAPT vs. SAPT
  • End of an era? Beta-blockers after acute MI
  • New guidelines for non-invasive coronary imaging
  • How low should you go? Hemoglobin targets in acute coronary syndromes
  • State-of-the-art management of systolic and diastolic heart failure
  • The MINT trial and 2025 guidelines for hemoglobin targets in ACS
  • More data to support GLP-1 receptor agonists for obesity-related HFpEF
  • Finerenone—new MRA on the block for HFpEF
  • Overcoming diuretic resistance in heart failure
  • Reducing readmissions for heart failure: best practices in discharge planning
  • Updated guidelines on atrial fibrillation management
  • The anticoagulation conundrum of sub-clinical atrial fibrillation
  • Rhythm control versus rate control for atrial fibrillation revisited
  • Should I continue SGLT2 inhibitors for my patient hospitalized with heart failure?
  • Should you switch anticoagulants in patients with breakthrough strokes?
  • Syncope: when to worry about cardiac causes  

 

DERMATOLOGY

  • Cellulitis: antibiotic dilemmas and when to call dermatology
  • New data on optimal treatment duration for skin and soft tissue infections
  • Drug reactions and other can't-miss dermatology diagnoses
  • Cutaneous findings of systemic disease
  • Differentiating skin infections and mimics in hospitalized patients
  • Cellulitis or venous stasis? Demystifying the swollen red leg
  • A cautionary tale: antibiotics with high risk of dermatologic reactions 

 

DIAGNOSTICS

  • Coronary CTA: as good as cardiac catheterization?
  • Can't-miss ECG diagnoses
  • Radiology pearls: identifying subtle findings on CXR
  • Rapid-fire review of electrolyte, liver, and hematology cases
  • Contrast or no contrast? Choosing the right imaging protocols

 

ENDOCRINE

  • Dangers of SGLT2 inhibitors: euglycemic DKA and UTIs
  • Difficult cases in hyperglycemia management
  • Continuous glucose monitoring in hospitalized patients with diabetes
  • New guidelines for the management of hyperglycemia in the hospital
  • Should we continue metformin in the hospital?
  • Adrenal insufficiency: whom to treat and how to taper steroids
  • Pitfalls in managing thyroid disease in medically ill patients
  • Practical approach to adrenal incidentalomas
  • When to worry about pheochromocytoma 

 

GASTROINTESTINAL

  • Diagnosis and management of hepatorenal syndrome
  • Covert hepatic encephalopathy: more common than you think
  • Evolving strategies for hepatorenal syndrome: terlipressin
  • New guidelines for spontaneous bacterial peritonitis management and prophylaxis
  • Managing the cirrhotic patient with bleeding and thrombosis
  • Updates on management of upper and lower GI bleeds
  • Optimal timing of endoscopy in upper GI bleeds
  • New risk scores to help manage patients with upper GI bleeds
  • Too soon? When to resume anticoagulation and antiplatelet agents after a GI bleed
  • Fluid resuscitation in acute pancreatitis: less is more
  • Optimal timing for intra-abdominal drainage in necrotizing pancreatitis
  • Urgent and non-urgent indications for ERCP
  • Current approaches to preventing post-ERCP pancreatitis
  • GLP-1 agonists and aspiration risk with endoscopy: harm or hype?
  • Topic to watch: SBP prophylaxis

 

GERIATRICS

  • Delirium: an ounce of prevention is worth a pound of cure
  • Non-pharmacologic interventions for delirium prevention
  • Time to rethink the need for routine QTc monitoring with haloperidol
  • Risk-stratified approach to antipsychotics and delirium  

 

 HEMATOLOGY

  • Management of patients with bleeding and thrombosis
  • Diagnosis and management of hypercoagulable states
  • Pearls for the diagnosis and management of thrombocytopenia
  • Diagnostic approach to anemia in the hospital
  • Application of venous thromboembolism guidelines
  • Is it ever OK to stop anticoagulation in unprovoked venous thrombosis?
  • What’s in a name: should we use “provoked” vs. “unprovoked” VTE?
  • Do they really need admission? Identifying the low-risk PE patient
  • Is low-dose apixaban the preferred strategy for cancer-associated thrombosis?
  • Is there a best-in-class DOAC?
  • More data on DOACs in patients with obesity and chronic kidney disease
  • Pearls for identifying myelodysplastic syndrome

 

INFECTIOUS DISEASES

  • ID pearls for selecting the right antibiotic
  • Ceftriaxone for pneumonia: 1g or 2g?
  • Comprehensive review of inpatient antibiotic therapy
  • When should we consult ID for bacteremia?
  • Expedited transitions from IV to oral antibiotics for common infections
  • 2025 data: settling the debate on MSSA bacteremia treatment
  • PrEP works, and hospitalists can help close the regional gap
  • Nice shot: twice-yearly lenacapavir provides HIV protection without the pills
  • Breakthroughs in MRSA therapeutics
  • When should we cover for MRSA pneumonia?
  • Should we be using CRP to risk stratify patients with severe CAP?
  • Whom should we screen for HIV in the inpatient setting?
  • Mirror, mirror, on the wall, what's the least "C-diffy" antibiotic of all?
  • Flying under the radar: C. difficile transmission in the hospital setting
  • Fecal microbiota therapy: more data as first-line treatment for C. difficile
  • C. difficile with reduced susceptibility to fidaxomicin
  • New treatment options for complicated UTIs
  • How to interpret the antibiogram
  • ESBL cultures—how scared should you be?   
  • 2025 IDSA guideline updates on diabetic foot infections
  • New treatment options for resistant infections 

 

NEUROLOGY

  • Approach to imaging in acute stroke syndromes
  • Updates on AHA/ASA guidelines for stroke management
  • Blood pressure management in acute stroke
  • Telestroke: an idea whose time has come?
  • To DAPT or not to DAPT: antiplatelet therapy in stroke and TIA
  • Thrombolysis in acute stroke: are we going to need a bigger window?
  • New agents for thrombolysis in acute stroke
  • Thrombectomy for acute stroke: is it underused?
  • Bleeding risk in stroke due to atrial fibrillation: when is it safe to start a DOAC?
  • Avoiding hemorrhagic transformation in stroke: when is it safe to start anticoagulation?
  • Should you switch anticoagulants in patients with breakthrough strokes?
  • Diagnostic approach to the patient with recurrent syncope
  • Evidence-based tools for risk stratification in syncope
  • Orthostatic syncope: does midodrine help?  

 

PALLIATIVE CARE

  • Which patients benefit most from palliative care?
  • Patient-centered strategies for serious illness conversations in the hospital
  • Best practices for leading family meetings

 

PERIOPERATIVE MEDICINE

  • The first new AHA periop guidelines in 10 years—what the hospitalist needs to know
  • New guidelines on GLP-1 and SGLT2 management in perioperative settings
  • Updates on perioperative aspirin, statins, beta blockers, and ACE inhibitors
  • To hold or not to hold: understanding the latest on perioperative medication management
  • The importance of frailty in assessing perioperative risk
  • Reducing pulmonary risk in perioperative patients
  • Perioperative anticoagulation: when should patients be bridged?

 

PREGNANCY 

  • HELLP me: managing medical complications in pregnant and postpartum patients
  • Best practices for hypertension management during and after pregnancy
  • Benefits, risks, and contraindications to radiologic studies in pregnant patients
  • Periprocedural management of pregnant patients
  • Treatment guidelines for UTI in pregnancy 

 

PSYCHIATRY 

  • Pearls for managing patients with personality disorders in the hospital
  • Inpatient management of psychiatric medications
  • Diagnostic yield of neuroimaging for common psychiatric presentations
  • Capacity assessment: can this patient make their own decisions? 

  

PULMONARY/CRITICAL CARE 

  • Tailored steroid therapy in acute COPD exacerbations
  • Practical applications of the 2025 GOLD guidelines
  • Short-course antibiotics in COPD exacerbations
  • Current recommendations for supplemental and high-flow O2 in critical illness
  • Surviving Sepsis guidelines
  • Steroids in sepsis: who and when?
  • Prone to survive: body position and outcomes in acute hypoxic respiratory failure
  • High-flow nasal cannula: does it measure up to non-invasive ventilation in hypercarbic respiratory failure?
  • Does long-term oxygen therapy reduce hospitalization?
  • New data on sedation and ICU delirium: propofol vs. dexmedetomidine 

  

RENAL 

  • Preventing the progression of chronic kidney disease: another win for GLP-1 agonists
  • The latest on “kidney-saving” medications: GLP-1 agonists, SGLT-2 inhibitors, and finerenone
  • Watchful waiting for critically ill patients without emergent need for renal replacement therapy
  • Diagnostic approach to acute kidney injury
  • Dialysis access: what the hospitalist needs to know
  • PICC and choose: IV access in end-stage renal disease patients
  • Ironing it out: managing anemia in ESRD
  • Blood pressure management in ESRD
  • Are we too scared of metformin?
  • Updates on hyperkalemia and hyperphosphatemia management
  • Stop using formulas to correct calcium; use ionized calcium to guide repletion
  • Should urea be used for managing SIADH?
  • Are we playing it too safe in hyponatremia?
  • Contrast nephropathy: an idea whose time has gone?

 

RHEUMATOLOGY

  • Block the rebound: anti-inflammatory cover for gout after starting urate-lowering therapy
  • See the halo, skip the scalpel—how to make the GCA diagnosis without a biopsy
  • When to call rheumatology
  • Dual forces for lupus nephritis: pulse dose steroids plus immunomodulators for active disease